VERDEYA

What this means for you

Not registered yet, but its 22 Apr 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

99148411

Mark type

Stylized text

Filed

22 Apr 2025

Attorney of record

Tamar Niv Bessinger

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical products, nutraceuticals, vitamins and dietary supplements for topical administration containing hemp-derived cannabinoids with a delta-9 THC concentration of not more than 0.3% on a dry weight basis; Pharmaceutical products and nutraceuticals for the treatment of pain, insomnia and sleep disorders, fever, cold, flu, allergy, gastro-intestinal disorders, and to improve energy, mood, quality and quantity of sleep; Pharmaceutical products, preparations, and nutraceuticals for topical administration for the treatment of pain, insomnia and sleep disorders, fever, cold, flu, allergy, gastro-intestinal disorders, and to improve energy, mood, quality and quantity of sleep containing hemp-derived cannabinoids with a delta-9 THC concentration of not more than 0.3% on a dry weight basis; Vitamins and dietary supplements; Inhaled pharmaceutical preparations for the treatment of pain, insomnia and sleep disorders, fever, cold, flu, allergy, gastro-intestinal disorders, and to improve energy, mood, quality and quantity of sleep; Pharmaceutical preparations for the treatment of pain, insomnia and sleep disorders, fever, cold, flu, allergy, gastro-intestinal disorders, and to improve energy, mood, quality and quantity of sleep in the form of chewable tablets, medicated gum, medicated lozenges, and powdered nutritional supplement drink mix; nicotine chewing gum for use as an aid to stop smoking; dietetic beverages adapted for medical purposes; tobacco-free cigarettes for smoking cessation purposes
• Class 010 — Medical apparatus: Medical devices for use in treating or diagnosing pain, insomnia and sleep disorders, fever, cold, flu, allergy, gastro-intestinal disorders, and to improve energy, mood, quality and quantity of sleep; Medical apparatus for facilitating the inhalation of pharmaceutical preparations; Inhalers for medical purposes, sold empty; dry powder inhalers (DPI) for medical purposes, sold empty; nebulizers for medical purposes; pressurized metered-dose inhalers (pMDI) for medical purposes, sold empty
• Class 032 — Light beverages: Non-alcoholic carbonated beverages; Powders for making effervescent isotonic beverages; Energy drinks; Isotonic beverages; Protein-enriched sports beverages; Whey beverages; Syrups for making non-alcoholic fruit juice beverages
• Class 034 — Smokers' articles: Oral vaporizers for smoking purposes; devices for heating tobacco substitutes for the purpose of inhalation; cases for electronic cigarettes, oral vaporizers for smoking purposes, and devices for heating tobacco substitutes for the purpose of inhalation; tobacco substitutes, not for medical purposes; sticks of tobacco substitute for the purpose of being heated for inhalation
• Class 042 — Scientific and technological services: Medical research services; scientific research; pharmaceutical drug development services; research and development of medicines, namely, inhaled therapeutics; research and development of new products in the field of pharmaceuticals, namely, products for oral and intra-oral delivery systems
• Class 044 — Medical, beauty and agricultural services: Medical services; medical services in the field of inhaled therapeutics and pharmaceuticals and in the field of oral administration of pharmaceuticals

Owner

• Aspeya Switzerland SA, Lausanne, CH

Prosecution history

• 04 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 04 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 04 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 15 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 15 Sept 2025 — NON-FINAL ACTION E-MAILED
• 15 Sept 2025 — NON-FINAL ACTION WRITTEN
• 15 Sept 2025 — ASSIGNED TO EXAMINER
• 29 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 22 Apr 2025 — APPLICATION FILING RECEIPT MAILED
• 22 Apr 2025 — NEW APPLICATION ENTERED